메뉴 건너뛰기




Volumn 22, Issue 12, 2013, Pages 1295-1308

The challenge of pregnancy for patients with SLE

Author keywords

management; medications; pre pregnancy counselling; Pregnancy; systemic lupus erythematosus

Indexed keywords

AMBRISENTAN; AZATHIOPRINE; BELIMUMAB; BETAMETHASONE; BOSENTAN; CHLOROQUINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; HYDRALAZINE; HYDROXYCHLOROQUINE; ILOPROST; IMMUNOGLOBULIN; LABETALOL; MEPACRINE; METHOTREXATE; METHYLDOPA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISONE; PROSTACYCLIN; RITUXIMAB; SILDENAFIL; SITAXSENTAN; TACROLIMUS; TADALAFIL; UNINDEXED DRUG;

EID: 84885595540     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313504637     Document Type: Article
Times cited : (35)

References (196)
  • 1
    • 36448957611 scopus 로고    scopus 로고
    • A population-based assessment of systemic lupus erythematosus incidence and prevalence-results and implications of using administrative data for epidemiological studies
    • Bernatsky S, Joseph L, Pineau CA, Tamblyn R, Feldman DE, Clarke AE. A population-based assessment of systemic lupus erythematosus incidence and prevalence-results and implications of using administrative data for epidemiological studies. Rheumatology (Oxford). 2007 ; 46: 1814-1818
    • (2007) Rheumatology (Oxford) , vol.46 , pp. 1814-1818
    • Bernatsky, S.1    Joseph, L.2    Pineau, C.A.3    Tamblyn, R.4    Feldman, D.E.5    Clarke, A.E.6
  • 2
    • 83055189208 scopus 로고    scopus 로고
    • 4th ed. Philadelphia, PA: Mosby Elsevier, 2008, pp. 1211-1216. Hochberg MC Silman AJ Smolen JS, ed. Philadelphia, PA: Mosby Elsevier
    • Domsic RT, Ramsey-Goldman R, Manzi S Rheumatology. 4 th ed. Philadelphia, PA: Mosby Elsevier, 2008, pp. 1211-1216. Hochberg MC Silman AJ Smolen JS, ed. Philadelphia, PA: Mosby Elsevier ; 2008: 1211-1216.
    • (2008) Rheumatology , pp. 1211-1216
    • Domsic, R.T.1    Ramsey-Goldman, R.2    Manzi, S.3
  • 3
    • 24944445033 scopus 로고    scopus 로고
    • Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period
    • Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol. 2005 ; 32: 1709-1712
    • (2005) J Rheumatol , vol.32 , pp. 1709-1712
    • Clark, C.A.1    Spitzer, K.A.2    Laskin, C.A.3
  • 4
    • 33750208773 scopus 로고    scopus 로고
    • Predictors of post-partum damage accrual in systemic lupus erythematosus: Data from LUMINA, a multiethnic US cohort (XXXVIII)
    • Andrade RM, McGwin G, Alarcon GS, et al. Predictors of post-partum damage accrual in systemic lupus erythematosus: Data from LUMINA, a multiethnic US cohort (XXXVIII). Rheumatology. 2006 ; 45: 1380-1384
    • (2006) Rheumatology , vol.45 , pp. 1380-1384
    • Andrade, R.M.1    McGwin, G.2    Alarcon, G.S.3
  • 5
    • 0021721582 scopus 로고
    • Lupus pregnancy: Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy
    • Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D. Lupus pregnancy: Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med. 1984 ; 77: 893-898
    • (1984) Am J Med , vol.77 , pp. 893-898
    • Lockshin, M.D.1    Reinitz, E.2    Druzin, M.L.3    Murrman, M.4    Estes, D.5
  • 6
    • 0022888665 scopus 로고
    • Prospective study of pregnancy in systemic lupus erythematosus: Results of a multi-disciplinary approach
    • Mintz G, Nitz J, Gutierrez G, et al. Prospective study of pregnancy in systemic lupus erythematosus: Results of a multi-disciplinary approach. J Rheumatol. 1986 ; 13: 732-739
    • (1986) J Rheumatol , vol.13 , pp. 732-739
    • Mintz, G.1    Nitz, J.2    Gutierrez, G.3
  • 7
    • 0026329304 scopus 로고
    • Frequency of lupus flare in pregnancy: The Hopkins lupus pregnancy center experience
    • Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy: The Hopkins lupus pregnancy center experience. Arthritis Rheum. 1991 ; 34: 1538-1545
    • (1991) Arthritis Rheum , vol.34 , pp. 1538-1545
    • Petri, M.1    Howard, D.2    Repke, J.3
  • 8
    • 0025978085 scopus 로고
    • Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study
    • Wong KL, Chan FY, Lee XP. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med. 1991 ; 151: 269-273
    • (1991) Arch Intern Med , vol.151 , pp. 269-273
    • Wong, K.L.1    Chan, F.Y.2    Lee, X.P.3
  • 10
    • 0029984467 scopus 로고    scopus 로고
    • Increased rate of lupus flare during pregnancy and the puerperium
    • Ruiz-Irastorza G, Lima F, Alves J, et al. Increased rate of lupus flare during pregnancy and the puerperium. Br J Rheumatol. 1996 ; 35: 133-138
    • (1996) Br J Rheumatol , vol.35 , pp. 133-138
    • Ruiz-Irastorza, G.1    Lima, F.2    Alves, J.3
  • 13
    • 0346353779 scopus 로고    scopus 로고
    • Outcome of planned pregnancies in systemic lupus erythematosus: A prospective study on 62 pregnancies
    • Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, et al. Outcome of planned pregnancies in systemic lupus erythematosus: A prospective study on 62 pregnancies. Br J Rheumatol. 1997 ; 36: 772-777
    • (1997) Br J Rheumatol , vol.36 , pp. 772-777
    • Le Thi Huong, D.1    Wechsler, B.2    Vauthier-Brouzes, D.3
  • 14
    • 13444268965 scopus 로고    scopus 로고
    • The impact of increased lupus activity on obstetrical outcomes
    • Clowse ME, Witter FR, Magder LC, Petri M. The impact of increased lupus activity on obstetrical outcomes. Arthritis Rheum. 2005 ; 52: 514-522
    • (2005) Arthritis Rheum , vol.52 , pp. 514-522
    • Clowse, M.E.1    Witter, F.R.2    Magder, L.C.3    Petri, M.4
  • 15
    • 13444267439 scopus 로고    scopus 로고
    • Pregnancy after lupus nephritis
    • Moroni G, Ponticelli C. Pregnancy after lupus nephritis. Lupus. 2005 ; 14: 89-94
    • (2005) Lupus , vol.14 , pp. 89-94
    • Moroni, G.1    Ponticelli, C.2
  • 16
    • 58449133991 scopus 로고    scopus 로고
    • Pregnancy in women with pre-existing lupus nephritis: Predictors of fetal and maternal outcome
    • Imbasciati E, Tincani A, Gregorini G, et al. Pregnancy in women with pre-existing lupus nephritis: Predictors of fetal and maternal outcome. Nephrol Dial Transplant. 2009 ; 24: 519-525
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 519-525
    • Imbasciati, E.1    Tincani, A.2    Gregorini, G.3
  • 17
    • 10644283014 scopus 로고    scopus 로고
    • Pregnancy outcome in women with pre-existing lupus nephritis
    • Soubassi L, Haidopoulos D, Sindos M, et al. Pregnancy outcome in women with pre-existing lupus nephritis. J Obs Gynaecol. 2004 ; 24: 630-634
    • (2004) J Obs Gynaecol , vol.24 , pp. 630-634
    • Soubassi, L.1    Haidopoulos, D.2    Sindos, M.3
  • 19
    • 33645966207 scopus 로고    scopus 로고
    • Lupus nephritis and renal disease in pregnancy
    • Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus. 2006 ; 15: 148-155
    • (2006) Lupus , vol.15 , pp. 148-155
    • Germain, S.1    Nelson-Piercy, C.2
  • 20
    • 38949163712 scopus 로고    scopus 로고
    • Chronic disease in pregnancy
    • Williams D, Davidson J. Chronic disease in pregnancy. BMJ. 2008 ; 336: 211-215
    • (2008) BMJ , vol.336 , pp. 211-215
    • Williams, D.1    Davidson, J.2
  • 21
    • 34249078071 scopus 로고    scopus 로고
    • Pregnancy in CKD stages 3 to 5: Fetal and maternal outcomes
    • Imbasciati E, Gregorini G, Cabiddu G, et al. Pregnancy in CKD stages 3 to 5: Fetal and maternal outcomes. Am J Kidney Dis. 2007 ; 49: 753-762
    • (2007) Am J Kidney Dis , vol.49 , pp. 753-762
    • Imbasciati, E.1    Gregorini, G.2    Cabiddu, G.3
  • 22
    • 34248154135 scopus 로고    scopus 로고
    • The Hopkins lupus pregnancy center: Ten key issues in management
    • Petri M. The Hopkins lupus pregnancy center: Ten key issues in management. Rheum Dis N Am. 2007 ; 33: 227-235
    • (2007) Rheum Dis N Am , vol.33 , pp. 227-235
    • Petri, M.1
  • 23
    • 73449120372 scopus 로고    scopus 로고
    • Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: A systematic review
    • Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: A systematic review. Ann Rheum Dis. 2010 ; 69: 20-28
    • (2010) Ann Rheum Dis , vol.69 , pp. 20-28
    • Ruiz-Irastorza, G.1    Ramos-Casals, M.2    Brito-Zeron, P.3    Khamashta, M.A.4
  • 24
    • 0034990187 scopus 로고    scopus 로고
    • Hydroxychloroquine (HCQ) in lupus pregnancy: Double-blind and placebo-controlled study
    • Levy RA, Vilela VS, Cataldo MJ, et al. Hydroxychloroquine (HCQ) in lupus pregnancy: Double-blind and placebo-controlled study. Lupus. 2001 ; 10: 401-404
    • (2001) Lupus , vol.10 , pp. 401-404
    • Levy, R.A.1    Vilela, V.S.2    Cataldo, M.J.3
  • 26
    • 0032735906 scopus 로고    scopus 로고
    • Assessing disease activity in SLE patients during pregnancy
    • Buyon JP, Kalunian KC, Ramsey-Goldman R, et al. Assessing disease activity in SLE patients during pregnancy. Lupus. 1999 ; 8: 677-684
    • (1999) Lupus , vol.8 , pp. 677-684
    • Buyon, J.P.1    Kalunian, K.C.2    Ramsey-Goldman, R.3
  • 27
    • 0016171910 scopus 로고
    • Studies of complement levels in normal human pregnancy
    • Baines MG, Millar KG, Mills P. Studies of complement levels in normal human pregnancy. Obstet Gynecol. 1974 ; 43: 806-810
    • (1974) Obstet Gynecol , vol.43 , pp. 806-810
    • Baines, M.G.1    Millar, K.G.2    Mills, P.3
  • 28
    • 0031747446 scopus 로고    scopus 로고
    • Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996
    • Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998 ; 31: 1650-1657
    • (1998) J Am Coll Cardiol , vol.31 , pp. 1650-1657
    • Weiss, B.M.1    Zemp, L.2    Seifert, B.3    Hess, O.M.4
  • 29
    • 44849098246 scopus 로고    scopus 로고
    • Heart disease, pregnancy and systemic autoimmune diseases
    • Oakley C, Warnes CA, (eds) 2nd ed. Blackwell Publishing
    • Ruiz-Irastorza G, Khamashta MA, Hughes GRV. Heart disease, pregnancy and systemic autoimmune diseases. In: Oakley C, Warnes CA, (eds) Heart disease in pregnancy. 2nd ed. Blackwell Publishing, 2007, pp.136-150.
    • (2007) Heart Disease in Pregnancy , pp. 136-150
    • Ruiz-Irastorza, G.1    Khamashta, M.A.2    Hughes, G.R.V.3
  • 30
    • 21144466750 scopus 로고    scopus 로고
    • Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases
    • Bonnin M, Mercier FJ, Sitbon O, et al. Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology. 2005 ; 102: 1133-1137
    • (2005) Anesthesiology , vol.102 , pp. 1133-1137
    • Bonnin, M.1    Mercier, F.J.2    Sitbon, O.3
  • 31
    • 84866124311 scopus 로고    scopus 로고
    • Perioperative management for parturients with pulmonary hypertension: Experience with 30 consecutive cases
    • Ma L, Liu W, Huang Y. Perioperative management for parturients with pulmonary hypertension: Experience with 30 consecutive cases. Front Med. 2012 ; 6: 307-310
    • (2012) Front Med , vol.6 , pp. 307-310
    • Ma, L.1    Liu, W.2    Huang, Y.3
  • 32
    • 0036222523 scopus 로고    scopus 로고
    • Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus
    • Doria A, Cutolo M, Ghirardello A, et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum. 2002 ; 47: 202-209
    • (2002) Arthritis Rheum , vol.47 , pp. 202-209
    • Doria, A.1    Cutolo, M.2    Ghirardello, A.3
  • 33
    • 1242269400 scopus 로고    scopus 로고
    • Measuring systemic lupus erythematosus activity during pregnancy: Validation of the Lupus Activity Index in Pregnancy scale
    • Ruiz-Irastorza G, Khamashta MA, Gordon C, et al. Measuring systemic lupus erythematosus activity during pregnancy: Validation of the Lupus Activity Index in Pregnancy scale. Arthritis Rheum. 2004 ; 51: 78-82
    • (2004) Arthritis Rheum , vol.51 , pp. 78-82
    • Ruiz-Irastorza, G.1    Khamashta, M.A.2    Gordon, C.3
  • 34
    • 47949126782 scopus 로고    scopus 로고
    • A national study of the complications of lupus in pregnancy
    • Clowse MEB, Jamison M, Myesr E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008 ; 199: 127.e1- - e6
    • (2008) Am J Obstet Gynecol , vol.199
    • Meb, C.1    Jamison, M.2    Myesr, E.3    James, A.H.4
  • 35
    • 84880317191 scopus 로고    scopus 로고
    • Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study
    • Hamed HO, Ahmed SR, Alzolibani A, et al. Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study. Acta Obstet Gynecol Scand. 2013 ; 92: 934-942
    • (2013) Acta Obstet Gynecol Scand , vol.92 , pp. 934-942
    • Hamed, H.O.1    Ahmed, S.R.2    Alzolibani, A.3
  • 36
    • 85056070722 scopus 로고    scopus 로고
    • Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: Results from a case control study and literature review
    • Yan Yuen S, Krizova A, Ouimet JM, Pope JE. Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: Results from a case control study and literature review. Open Rheumatol J. 2008 ; 2: 89-98
    • (2008) Open Rheumatol J , vol.2 , pp. 89-98
    • Yan Yuen, S.1    Krizova, A.2    Ouimet, J.M.3    Pope, J.E.4
  • 37
    • 79957829051 scopus 로고    scopus 로고
    • The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus
    • Clowse ME, Magder LS, Petri M. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. J Rheumatol. 2011 ; 38: 1012-1016
    • (2011) J Rheumatol , vol.38 , pp. 1012-1016
    • Clowse, M.E.1    Magder, L.S.2    Petri, M.3
  • 38
    • 79957592911 scopus 로고    scopus 로고
    • Thyroid disease in pregnant women with systemic lupus erythematosus: Increased preterm delivery
    • Stagnaro-Green A, Akhter E, Yim C, Davies TF, Magder L, Petri M. Thyroid disease in pregnant women with systemic lupus erythematosus: Increased preterm delivery. Lupus. 2011 ; 20: 690-699
    • (2011) Lupus , vol.20 , pp. 690-699
    • Stagnaro-Green, A.1    Akhter, E.2    Yim, C.3    Davies, T.F.4    Magder, L.5    Petri, M.6
  • 40
    • 0027094294 scopus 로고
    • The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome
    • Hayslett JP. The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome. Am J Reprod Immunol. 1992 ; 28: 199-204
    • (1992) Am J Reprod Immunol , vol.28 , pp. 199-204
    • Hayslett, J.P.1
  • 42
    • 0141754190 scopus 로고    scopus 로고
    • Preterm deliveries in women with systemic lupus erythematosus
    • Clark CA, Spitzer KA, Nadler JN, Laskin CA. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol. 2003 ; 30: 2127-2132
    • (2003) J Rheumatol , vol.30 , pp. 2127-2132
    • Clark, C.A.1    Spitzer, K.A.2    Nadler, J.N.3    Laskin, C.A.4
  • 44
    • 84874403699 scopus 로고    scopus 로고
    • Second pregnancy outcomes for women with systemic lupus erythematosus
    • Shand AW, Algert CS, March L, Roberts CL. Second pregnancy outcomes for women with systemic lupus erythematosus. Ann Rheum Dis. 2013 ; 72: 547-551
    • (2013) Ann Rheum Dis , vol.72 , pp. 547-551
    • Shand, A.W.1    Algert, C.S.2    March, L.3    Roberts, C.L.4
  • 45
    • 80051766075 scopus 로고    scopus 로고
    • Decreased live births in women with systemic lupus erythematosus
    • Vinet E, Clarke AE, Gordon C, et al. Decreased live births in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011 ; 63: 1068-1072
    • (2011) Arthritis Care Res (Hoboken) , vol.63 , pp. 1068-1072
    • Vinet, E.1    Clarke, A.E.2    Gordon, C.3
  • 46
    • 20444433640 scopus 로고    scopus 로고
    • Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus
    • Chakravarty EF, Colon I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005 ; 192: 1897-1904
    • (2005) Am J Obstet Gynecol , vol.192 , pp. 1897-1904
    • Chakravarty, E.F.1    Colon, I.2    Langen, E.S.3
  • 47
    • 43349104778 scopus 로고    scopus 로고
    • Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI)
    • Andrade R, Sanchez ML, Alarcon GS, et al. Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI). Clin Exp Rheumatol. 2008 ; 26: 268-274
    • (2008) Clin Exp Rheumatol , vol.26 , pp. 268-274
    • Andrade, R.1    Sanchez, M.L.2    Alarcon, G.S.3
  • 48
    • 78149308775 scopus 로고    scopus 로고
    • A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis
    • Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010 ; 5: 2060-2068
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 2060-2068
    • Smyth, A.1    Oliveira, G.H.2    Lahr, B.D.3    Bailey, K.R.4    Norby, S.M.5    Garovic, V.D.6
  • 50
    • 0348150705 scopus 로고    scopus 로고
    • Pregnancy outcomes in female renal recipients: A comparison of systemic lupus erythematosus with other diagnoses
    • McGrory CH, McCloskey LJ, DeHoratius RJ, Dunn SR, Moritz MJ, Armenti VT. Pregnancy outcomes in female renal recipients: A comparison of systemic lupus erythematosus with other diagnoses. Am J Transplant. 2003 ; 3: 35-42
    • (2003) Am J Transplant , vol.3 , pp. 35-42
    • McGrory, M.1    McCloskey, L.J.2    Dehoratius, R.J.3    Dunn, S.R.4    Moritz, M.J.5    Armenti, V.T.6
  • 52
    • 0042521155 scopus 로고    scopus 로고
    • The risk of pregnancy in patients with lupus nephritis
    • Moroni G, Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J Nephrol. 2003 ; 16: 161-167
    • (2003) J Nephrol , vol.16 , pp. 161-167
    • Moroni, G.1    Ponticelli, C.2
  • 53
    • 33644910144 scopus 로고    scopus 로고
    • Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis
    • Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006 ; 54: 899-907
    • (2006) Arthritis Rheum , vol.54 , pp. 899-907
    • Chakravarty, E.F.1    Nelson, L.2    Krishnan, E.3
  • 54
    • 0031980705 scopus 로고    scopus 로고
    • For the maternal-fetal medicine units network of the national institute of child health and human development. The preterm prediction study: Risk factors for indicated preterm births
    • Meis PJ, Goldenberg RL, Mercer BM, et al. for the Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. The preterm prediction study: risk factors for indicated preterm births. Am J Obstet Gynecol. 1998 ; 178: 562-567
    • (1998) Am J Obstet Gynecol , vol.178 , pp. 562-567
    • Meis, P.J.1    Goldenberg, R.L.2    Mercer, B.M.3
  • 55
    • 20144367499 scopus 로고    scopus 로고
    • The pre-eclampsia community guideline (PRECOG): How to screen for and detect onset of pre-eclampsia in the community
    • Milne F, Redman C, Walker J, et al. The pre-eclampsia community guideline (PRECOG): How to screen for and detect onset of pre-eclampsia in the community. Br Med J. 2005 ; 330: 576-580
    • (2005) Br Med J , vol.330 , pp. 576-580
    • Milne, F.1    Redman, C.2    Walker, J.3
  • 56
    • 84885616514 scopus 로고    scopus 로고
    • National Institute for Health and Clinical Excellence. Hypertension in pregnancy: The management of hypertensive disorders during pregnancy (clinical guideline 107) accessed August 2013
    • National Institute for Health and Clinical Excellence. Hypertension in pregnancy: The management of hypertensive disorders during pregnancy (clinical guideline 107), www.nice.org.uk/CG107 (2010, accessed August 2013).
    • (2010)
  • 57
    • 84885664883 scopus 로고    scopus 로고
    • Management of sickle cell disease in pregnancy. Green Top Guideline 61. Royal College of Obstetricians and Gynaecologists, London accessed August 2013
    • Management of sickle cell disease in pregnancy. Green Top Guideline 61. Royal College of Obstetricians and Gynaecologists, London, www.rcog.org.uk/ womens-health/clinical-guidance/sickle-cell-disease-pregnancy-management-green- top-61 (2011, accessed August 2013).
    • (2011)
  • 58
    • 79955613224 scopus 로고    scopus 로고
    • Lupus and pregnancy: Integrating clues from the bench and bedside
    • Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: Integrating clues from the bench and bedside. Eur J Clin Invest. 2011 ; 41: 672-678
    • (2011) Eur J Clin Invest , vol.41 , pp. 672-678
    • Ruiz-Irastorza, G.1    Khamashta, M.A.2
  • 59
    • 0034771094 scopus 로고    scopus 로고
    • Renal biopsy in pregnancies complicated by undetermined renal disease
    • Chen HH, Lin HC, Yeh JC, Chen CP. Renal biopsy in pregnancies complicated by undetermined renal disease. Acta Obstet Gynecol Scand. 2001 ; 80: 888-893
    • (2001) Acta Obstet Gynecol Scand , vol.80 , pp. 888-893
    • Chen, H.H.1    Lin, H.C.2    Yeh, J.C.3    Chen, C.P.4
  • 60
    • 0036228886 scopus 로고    scopus 로고
    • Antiphospholipid syndrome: Clinical and immunologic manifestations and pattern of disease expression in a cohort of 1.000 patients
    • Cervera R, Khamashta MA, Font J, et al. Antiphospholipid syndrome: Clinical and immunologic manifestations and pattern of disease expression in a cohort of 1.000 patients. Arthritis Rheum. 2002 ; 46: 1019-1027
    • (2002) Arthritis Rheum , vol.46 , pp. 1019-1027
    • Cervera, R.1    Khamashta, M.A.2    Font, J.3
  • 61
    • 68949175636 scopus 로고    scopus 로고
    • The Euro-Phospholipid project: Epidemiology of the antiphospholipid syndrome in Europe
    • Cervera R, Boffa MC, Khamashta MA, Hughes GR. The Euro-Phospholipid project: Epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009 ; 18: 889-893
    • (2009) Lupus , vol.18 , pp. 889-893
    • Cervera, R.1    Boffa, M.C.2    Khamashta, M.A.3    Hughes, G.R.4
  • 63
    • 0028197405 scopus 로고
    • Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study
    • Lynch A, Marlar R, Murphy J, et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Inten Med. 1994 ; 120: 470-475
    • (1994) Ann Inten Med , vol.120 , pp. 470-475
    • Lynch, A.1    Marlar, R.2    Murphy, J.3
  • 64
    • 0029075832 scopus 로고
    • Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy
    • Yasuda M, Tkakuwa K, Tokunaga A, Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol. 1995 ; 86: 555-559
    • (1995) Obstet Gynecol , vol.86 , pp. 555-559
    • Yasuda, M.1    Tkakuwa, K.2    Tokunaga, A.3    Tanaka, K.4
  • 65
    • 0029866061 scopus 로고    scopus 로고
    • Beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women
    • Katano K, Aoki A, Sasa H, Ogawara M, Matsumura E, Yagami Y. Beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod. 1996 ; 11: 509-512
    • (1996) Hum Reprod , vol.11 , pp. 509-512
    • Katano, K.1    Aoki, A.2    Sasa, H.3    Ogawara, M.4    Matsumura, E.5    Yagami, Y.6
  • 66
    • 0030991876 scopus 로고    scopus 로고
    • Anti-beta 2 glycoprotein i antibodies in a general obstetric population: Preliminary results on the prevalence and correlation with pregnancy outcome
    • Faden D, Tincani A, Tanzi P, et al. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: Preliminary results on the prevalence and correlation with pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 1997 ; 73: 37-42
    • (1997) Eur J Obstet Gynecol Reprod Biol , vol.73 , pp. 37-42
    • Faden, D.1    Tincani, A.2    Tanzi, P.3
  • 67
    • 61849105454 scopus 로고    scopus 로고
    • Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes
    • Yamada H, Atsumi T, Kobashi G, et al. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J Reprod Immunol. 2009 ; 79: 188-195
    • (2009) J Reprod Immunol , vol.79 , pp. 188-195
    • Yamada, H.1    Atsumi, T.2    Kobashi, G.3
  • 68
    • 63849199989 scopus 로고    scopus 로고
    • Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: Analysis of a population-based hospital dataset
    • Nodler J, Moolamalla SR, Ledger EM, Nuwayhid BS, Mulla ZD. Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: Analysis of a population-based hospital dataset. BMC Pregnancy Childbirth. 2009 ; 9: 11-11
    • (2009) BMC Pregnancy Childbirth , vol.9 , pp. 11-11
    • Nodler, J.1    Moolamalla, S.R.2    Ledger, E.M.3    Nuwayhid, B.S.4    Mulla, Z.D.5
  • 69
    • 73249143319 scopus 로고    scopus 로고
    • Glycoprotein-I antibody increases the risk of pregnancy-induced hypertension: A case-controlled study
    • Yamada H, Atsumi T, Amengual O, et al. Glycoprotein-I antibody increases the risk of pregnancy-induced hypertension: A case-controlled study. J Reprod Immunol. 2010 ; 84: 95-99
    • (2010) J Reprod Immunol , vol.84 , pp. 95-99
    • Yamada, H.1    Atsumi, T.2    Amengual, O.3
  • 70
    • 78650133588 scopus 로고    scopus 로고
    • Association of anticardiolipin antibodies with preeclampsia
    • do Prado D, Piovesan M, Staub L, Horta L. Association of anticardiolipin antibodies with preeclampsia. Obstet Ginecol. 2010 ; 116: 1433-1443
    • (2010) Obstet Ginecol , vol.116 , pp. 1433-1443
    • Do Prado, D.1    Piovesan, M.2    Staub, L.3    Horta, L.4
  • 71
    • 77649215763 scopus 로고    scopus 로고
    • Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome
    • Ruffatti A, Calligaro A, Hoxha A, et al. Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome. Arthritis Care Res. 2010 ; 62: 302-307
    • (2010) Arthritis Care Res , vol.62 , pp. 302-307
    • Ruffatti, A.1    Calligaro, A.2    Hoxha, A.3
  • 72
    • 74849134126 scopus 로고    scopus 로고
    • Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome
    • Bramham K, Hunt BJ, Germain S, et al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus. 2010 ; 9: 58-64
    • (2010) Lupus , vol.9 , pp. 58-64
    • Bramham, K.1    Hunt, B.J.2    Germain, S.3
  • 73
    • 84863197776 scopus 로고    scopus 로고
    • Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies
    • Lockshin MD, Kim M, Laskin CM, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum. 2012 ; 64: 2311-2318
    • (2012) Arthritis Rheum , vol.64 , pp. 2311-2318
    • Lockshin, M.D.1    Kim, M.2    Laskin, C.M.3
  • 74
    • 84884630219 scopus 로고    scopus 로고
    • The lupus anticoagulant: Results from 2257 patients attending a high-risk pregnancy clinic
    • Clark CA, Davidovits J, Spitzer KA, Laskin CA. The lupus anticoagulant: Results from 2257 patients attending a high-risk pregnancy clinic. Blood. 2013 ; 122: 341-347
    • (2013) Blood , vol.122 , pp. 341-347
    • Clark, C.A.1    Davidovits, J.2    Spitzer, K.A.3    Laskin, C.A.4
  • 75
    • 33748444983 scopus 로고    scopus 로고
    • Systemic lupus erythematosus and pregnancy
    • Khamashta MA. Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol. 2006 ; 20: 685-694
    • (2006) Best Pract Res Clin Rheumatol , vol.20 , pp. 685-694
    • Khamashta, M.A.1
  • 76
    • 0142009533 scopus 로고    scopus 로고
    • Development of autoantibodies before the clinical onset of systemic lupus erythematosus
    • Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003 ; 349: 1526-1533
    • (2003) N Engl J Med , vol.349 , pp. 1526-1533
    • Arbuckle, M.R.1    McClain, M.T.2    Rubertone, M.V.3
  • 77
    • 29144445982 scopus 로고    scopus 로고
    • Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
    • To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?. Arthritis Rheum. 2005 ; 52: 4003-4010
    • (2005) Arthritis Rheum , vol.52 , pp. 4003-4010
    • To, C.H.1    Petri, M.2
  • 78
    • 22244459489 scopus 로고    scopus 로고
    • Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus
    • Faria AC, Barcellos KS, Andrade LE. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus. J Rheumatol. 2005 ; 32: 1267-1272
    • (2005) J Rheumatol , vol.32 , pp. 1267-1272
    • Faria, A.C.1    Barcellos, K.S.2    Andrade, L.E.3
  • 79
    • 41749105055 scopus 로고    scopus 로고
    • Clinical and immunological manifestations in 151 SLE patients living in Dubai
    • Alsaleh J, Jassim V, Elsayed M, Saleh N, Harb D. Clinical and immunological manifestations in 151 SLE patients living in Dubai. Lupus. 2008 ; 17: 62-66
    • (2008) Lupus , vol.17 , pp. 62-66
    • Alsaleh, J.1    Jassim, V.2    Elsayed, M.3    Saleh, N.4    Harb, D.5
  • 80
    • 34548447668 scopus 로고    scopus 로고
    • Congenital heart block: Clinical features and therapeutic approaches
    • Gordon PA. Congenital heart block: Clinical features and therapeutic approaches. Lupus. 2007 ; 16: 642-646
    • (2007) Lupus , vol.16 , pp. 642-646
    • Gordon, P.A.1
  • 81
    • 41849084808 scopus 로고    scopus 로고
    • Prevalence of disease-specific antinuclear antibodies in general population: Estimates from annual physical examinations of residents of a small town over a 5-year period
    • Hayashi N, Koshiba M, Nishimura K, et al. Prevalence of disease-specific antinuclear antibodies in general population: Estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol. 2008 ; 18: 153-160
    • (2008) Mod Rheumatol , vol.18 , pp. 153-160
    • Hayashi, N.1    Koshiba, M.2    Nishimura, K.3
  • 83
    • 77955296084 scopus 로고    scopus 로고
    • Non-cardiac manifestations of neonatal lupus erythematosus
    • Silverman E, Jaeggi E. Non-cardiac manifestations of neonatal lupus erythematosus. Scand J Immunol. 2010 ; 72: 223-225
    • (2010) Scand J Immunol , vol.72 , pp. 223-225
    • Silverman, E.1    Jaeggi, E.2
  • 84
    • 0034892863 scopus 로고    scopus 로고
    • Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women
    • Brucato A, Frassi M, Franceschini F, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women. Arthritis Rheum. 2001 ; 44: 1832-1835
    • (2001) Arthritis Rheum , vol.44 , pp. 1832-1835
    • Brucato, A.1    Frassi, M.2    Franceschini, F.3
  • 85
    • 77950533991 scopus 로고    scopus 로고
    • Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block
    • Izmirly PM, Llanos C, Lee LA, Askanase A, Kim MY, Buyon JP. Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block. Arthritis Rheum. 2010 ; 62: 1153-1157
    • (2010) Arthritis Rheum , vol.62 , pp. 1153-1157
    • Izmirly, P.M.1    Llanos, C.2    Lee, L.A.3    Askanase, A.4    Kim, M.Y.5    Buyon, J.P.6
  • 86
    • 68849097885 scopus 로고    scopus 로고
    • Congenital heart block not associated with anti-Ro/La antibodies: Comparison with anti-Ro/La-positive cases
    • Brucato A, Grava C, Bortolati M, et al. Congenital heart block not associated with anti-Ro/La antibodies: Comparison with anti-Ro/La-positive cases. J Rheumatol. 2009 ; 36: 1744-1748
    • (2009) J Rheumatol , vol.36 , pp. 1744-1748
    • Brucato, A.1    Grava, C.2    Bortolati, M.3
  • 87
    • 0027366698 scopus 로고
    • Maternal autoantibodies and congenital heart block: No evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile
    • Meilof JF, Frohn-Mulder IM, Stewart PA, et al. Maternal autoantibodies and congenital heart block: No evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile. Lupus. 1993 ; 2: 239-246
    • (1993) Lupus , vol.2 , pp. 239-246
    • Meilof, J.F.1    Frohn-Mulder, I.M.2    Stewart, P.A.3
  • 88
    • 80155155860 scopus 로고    scopus 로고
    • Isolated atrioventricular block in the fetus: A retrospective, multinational, multicenter study of 175 patients
    • Eliasson H, Sonesson SE, Sharland G, et al. Isolated atrioventricular block in the fetus: A retrospective, multinational, multicenter study of 175 patients. Circulation. 2011 ; 124: 1919-1926
    • (2011) Circulation , vol.124 , pp. 1919-1926
    • Eliasson, H.1    Sonesson, S.E.2    Sharland, G.3
  • 89
    • 84861473083 scopus 로고    scopus 로고
    • Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus
    • Llanos C, Friedman D, Saxena A, et al. Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus. Rheumatology. 2012 ; 51: 1086-1092
    • (2012) Rheumatology , vol.51 , pp. 1086-1092
    • Llanos, C.1    Friedman, D.2    Saxena, A.3
  • 90
    • 0031745967 scopus 로고    scopus 로고
    • Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry
    • Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998 ; 31: 1658-1666
    • (1998) J Am Coll Cardiol , vol.31 , pp. 1658-1666
    • Buyon, J.P.1    Hiebert, R.2    Copel, J.3
  • 91
    • 0033918291 scopus 로고    scopus 로고
    • Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn
    • Eronen M, Siren MK, Ekblad H, Tikanoja T, Julkunen H, Paavilainen T. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics. 2000 ; 106: 86-91
    • (2000) Pediatrics , vol.106 , pp. 86-91
    • Eronen, M.1    Siren, M.K.2    Ekblad, H.3    Tikanoja, T.4    Julkunen, H.5    Paavilainen, T.6
  • 92
    • 77955284867 scopus 로고    scopus 로고
    • Autoantibodies associated with congenital heart block
    • Salomonsson S, Strandberg L. Autoantibodies associated with congenital heart block. Scand J Immunol. 2010 ; 72: 185-188
    • (2010) Scand J Immunol , vol.72 , pp. 185-188
    • Salomonsson, S.1    Strandberg, L.2
  • 93
    • 77953101173 scopus 로고    scopus 로고
    • The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus: A prospective study of 186 antibody-exposed fetuses and infants
    • Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus: A prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol. 2010 ; 55: 2778-2784
    • (2010) J Am Coll Cardiol , vol.55 , pp. 2778-2784
    • Jaeggi, E.1    Laskin, C.2    Hamilton, R.3    Kingdom, J.4    Silverman, E.5
  • 94
    • 84871608207 scopus 로고    scopus 로고
    • Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents
    • Tunks RD, Clowse ME, Miller SG, Brancazio LR, Barker PC. Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents. Am J Obstet Gynecol. 2013 ; 208: 64.e1 - e7
    • (2013) Am J Obstet Gynecol , vol.208
    • Tunks, R.D.1    Clowse, M.E.2    Miller, S.G.3    Brancazio, L.R.4    Barker, P.C.5
  • 95
    • 0035162508 scopus 로고    scopus 로고
    • Congenital heart block: Development of late-onset cardiomyopathy, a previously underappreciated sequela
    • Moak JP, Barron KS, Hougen TJ, et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol. 2001 ; 37: 238-242
    • (2001) J Am Coll Cardiol , vol.37 , pp. 238-242
    • Moak, J.P.1    Barron, K.S.2    Hougen, T.J.3
  • 96
    • 79551699108 scopus 로고    scopus 로고
    • A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal anti-SSA/Ro and anti-SSB/La antibodies
    • Guettrot-Imbert G, Cohen L, Fermont L, et al. A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal anti-SSA/Ro and anti-SSB/La antibodies. J Rheumatol. 2011 ; 38: 378-386
    • (2011) J Rheumatol , vol.38 , pp. 378-386
    • Guettrot-Imbert, G.1    Cohen, L.2    Fermont, L.3
  • 97
    • 0037133337 scopus 로고    scopus 로고
    • Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis
    • Nield LE, Silverman ED, Taylor GP, et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation. 2002 ; 105: 843-848
    • (2002) Circulation , vol.105 , pp. 843-848
    • Nield, L.E.1    Silverman, E.D.2    Taylor, G.P.3
  • 98
    • 77955287824 scopus 로고    scopus 로고
    • Diagnosing foetal atrioventricular heart blocks
    • Sonesson SE. Diagnosing foetal atrioventricular heart blocks. Scand J Immunol. 2010 ; 72: 205-212
    • (2010) Scand J Immunol , vol.72 , pp. 205-212
    • Sonesson, S.E.1
  • 99
    • 70149106031 scopus 로고    scopus 로고
    • Prevention of congenital heart block in children of SSA-positive mothers
    • Brucato A. Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology (Oxford). 2008 ; 47: i35 - i37
    • (2008) Rheumatology (Oxford) , vol.47
    • Brucato, A.1
  • 100
    • 77955289906 scopus 로고    scopus 로고
    • The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: A review
    • Hutter D, Silverman ED, Jaeggi ET. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: A review. Scand J Immunol. 2010 ; 72: 235-241
    • (2010) Scand J Immunol , vol.72 , pp. 235-241
    • Hutter, D.1    Silverman, E.D.2    Jaeggi, E.T.3
  • 101
    • 63749103526 scopus 로고    scopus 로고
    • Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR interval and dexamethasone evaluation (PRIDE) study
    • Friedman DM, Kim MY, Copel JA, Llanos C, Davis C, Buyon JP. Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR interval and dexamethasone evaluation (PRIDE) study. Am J Cardiol. 2009 ; 103: 1102-1106
    • (2009) Am J Cardiol , vol.103 , pp. 1102-1106
    • Friedman, D.M.1    Kim, M.Y.2    Copel, J.A.3    Llanos, C.4    Davis, C.5    Buyon, J.P.6
  • 102
    • 0347719247 scopus 로고    scopus 로고
    • Intravenous immunoglobulin and placental transport of anti-Ro/La antibodies: Comment on the letter by Kaaja and Julkunen
    • Tran HB, Cavill D, Buyon JP, Gordon TP. Intravenous immunoglobulin and placental transport of anti-Ro/La antibodies: Comment on the letter by Kaaja and Julkunen. Arthritis Rheum. 2004 ; 50: 337-338
    • (2004) Arthritis Rheum , vol.50 , pp. 337-338
    • Tran, H.B.1    Cavill, D.2    Buyon, J.P.3    Gordon, T.P.4
  • 103
    • 77950538130 scopus 로고    scopus 로고
    • Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial
    • Friedman DM, Llanos C, Izmirly PM, et al. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum. 2010 ; 62: 1138-1146
    • (2010) Arthritis Rheum , vol.62 , pp. 1138-1146
    • Friedman, D.M.1    Llanos, C.2    Izmirly, P.M.3
  • 104
    • 77950538820 scopus 로고    scopus 로고
    • Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study
    • Pisoni CN, Brucato A, Ruffatti A, et al. Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. Arthritis Rheum. 2010 ; 62: 1147-1152
    • (2010) Arthritis Rheum , vol.62 , pp. 1147-1152
    • Pisoni, C.N.1    Brucato, A.2    Ruffatti, A.3
  • 105
    • 34548321503 scopus 로고    scopus 로고
    • Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome
    • Makino S, Yonemoto H, Itoh S, Takeda S. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome. Acta Obstet Gynecol Scand. 2007 ; 86: 1145-1146
    • (2007) Acta Obstet Gynecol Scand , vol.86 , pp. 1145-1146
    • Makino, S.1    Yonemoto, H.2    Itoh, S.3    Takeda, S.4
  • 106
    • 84863625124 scopus 로고    scopus 로고
    • Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus
    • Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation. 2012 ; 126: 76-82
    • (2012) Circulation , vol.126 , pp. 76-82
    • Izmirly, P.M.1    Costedoat-Chalumeau, N.2    Pisoni, C.N.3
  • 107
    • 0032726750 scopus 로고    scopus 로고
    • Pregnancy outcome and family size in systemic lupus erythematosus: A case-control study
    • Hardy CJ, Palmer BP, Morton SJ, Muir KR, Powell RJ. Pregnancy outcome and family size in systemic lupus erythematosus: A case-control study. Rheumatology. 1999 ; 38: 559-563
    • (1999) Rheumatology , vol.38 , pp. 559-563
    • Hardy, C.J.1    Palmer, B.P.2    Morton, S.J.3    Muir, K.R.4    Powell, R.J.5
  • 108
    • 80051933410 scopus 로고    scopus 로고
    • Causes and management of infertility in systemic lupus erythematosus
    • Hickman RA, Gordon C. Causes and management of infertility in systemic lupus erythematosus. Rheumatology (Oxford). 2011 ; 50: 1551-1558
    • (2011) Rheumatology (Oxford) , vol.50 , pp. 1551-1558
    • Hickman, R.A.1    Gordon, C.2
  • 110
    • 79952118035 scopus 로고    scopus 로고
    • Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs
    • Silva CA, Bonfa E, Ostensen M. Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs. Arthritis Care Res. 2010 ; 62: 1682-1690
    • (2010) Arthritis Care Res , vol.62 , pp. 1682-1690
    • Silva, C.A.1    Bonfa, E.2    Ostensen, M.3
  • 111
    • 0036340707 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory drugs and reversible female infertility: Is there a link?
    • Stone S, Khamashta MA, Nelson-Piercy C. Nonsteroidal anti-inflammatory drugs and reversible female infertility: Is there a link?. Drug Saf. 2002 ; 25: 545-551
    • (2002) Drug Saf , vol.25 , pp. 545-551
    • Stone, S.1    Khamashta, M.A.2    Nelson-Piercy, C.3
  • 112
    • 80052275639 scopus 로고    scopus 로고
    • Luteneized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies
    • Micu MC, Micu R, Ostensen M. Luteneized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies. Arthritis Care Res. 2011 ; 63: 1334-1338
    • (2011) Arthritis Care Res , vol.63 , pp. 1334-1338
    • Micu, M.C.1    Micu, R.2    Ostensen, M.3
  • 113
    • 0034045163 scopus 로고    scopus 로고
    • Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome
    • Guballa N, Sammaritano L, Schwartzman S, Buyon J, Lockshin MD. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum. 2000 ; 43: 550-556
    • (2000) Arthritis Rheum , vol.43 , pp. 550-556
    • Guballa, N.1    Sammaritano, L.2    Schwartzman, S.3    Buyon, J.4    Lockshin, M.D.5
  • 114
    • 0036926703 scopus 로고    scopus 로고
    • Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: A single center retrospective study of 21 cases and 114 cycles
    • Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, et al. Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: A single center retrospective study of 21 cases and 114 cycles. Semin Arthritis Rheum. 2002 ; 32: 174-188
    • (2002) Semin Arthritis Rheum , vol.32 , pp. 174-188
    • Le Thi Huong, D.1    Wechsler, B.2    Vauthier-Brouzes, D.3
  • 115
    • 70749086564 scopus 로고    scopus 로고
    • Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid sindrome
    • Bellver J, Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid sindrome. Fertil Steril. 2009 ; 92: 1803-1810
    • (2009) Fertil Steril , vol.92 , pp. 1803-1810
    • Bellver, J.1    Pellicer, A.2
  • 116
    • 0033830167 scopus 로고    scopus 로고
    • Management of patients with antiphospholipid antibodies undergoing in vitro fertilization
    • Udoff LC, Branch DW. Management of patients with antiphospholipid antibodies undergoing in vitro fertilization. J Autoimmun. 2000 ; 15: 209-211
    • (2000) J Autoimmun , vol.15 , pp. 209-211
    • Udoff, L.C.1    Branch, D.W.2
  • 117
    • 28544447610 scopus 로고    scopus 로고
    • Management of preterm infants with intrauterine growth restriction
    • Fang S. Management of preterm infants with intrauterine growth restriction. Early Hum Dev. 2005 ; 81: 889-900
    • (2005) Early Hum Dev , vol.81 , pp. 889-900
    • Fang, S.1
  • 118
    • 78650563353 scopus 로고    scopus 로고
    • Neuropsychiatric aid in children born to patients with rheumatic diseases
    • Bomba M, Galli J, Nacinovich R, et al. Neuropsychiatric aid in children born to patients with rheumatic diseases. Clin Exp Rheumatol. 2010 ; 28: 767-773
    • (2010) Clin Exp Rheumatol , vol.28 , pp. 767-773
    • Bomba, M.1    Galli, J.2    Nacinovich, R.3
  • 119
    • 46849119815 scopus 로고    scopus 로고
    • Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus
    • Urowitz MB, Gladman DD, MacKinnon A, et al. Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus. Lupus. 2008 ; 17: 555-560
    • (2008) Lupus , vol.17 , pp. 555-560
    • Urowitz, M.B.1    Gladman, D.D.2    Mackinnon, A.3
  • 120
    • 4644301375 scopus 로고    scopus 로고
    • Neuropsychological development of children born to patients with systemic lupus erythematosus
    • Neri F, Chimini L, Bonomi F, et al. Neuropsychological development of children born to patients with systemic lupus erythematosus. Lupus. 2004 ; 13: 805-811
    • (2004) Lupus , vol.13 , pp. 805-811
    • Neri, F.1    Chimini, L.2    Bonomi, F.3
  • 121
    • 84871019358 scopus 로고    scopus 로고
    • Neurodevelopment in children with and without congenital heart block born to anti-Ro/SSA-positive mothers
    • Skog A, Tingström J, Salomonsson S, Sonesson SE, Wahren-Herlenius M. Neurodevelopment in children with and without congenital heart block born to anti-Ro/SSA-positive mothers. Acta Paediatr. 2013 ; 102: 40-46
    • (2013) Acta Paediatr , vol.102 , pp. 40-46
    • Skog, A.1    Tingström, J.2    Salomonsson, S.3    Sonesson, S.E.4    Wahren-Herlenius, M.5
  • 122
    • 84872068620 scopus 로고    scopus 로고
    • European registry of babies born to mothers with antiphospholipid syndrome
    • Mekinian A, Lachassinne E, Nicaise-Roland P, et al. European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis. 2013 ; 72: 217-222
    • (2013) Ann Rheum Dis , vol.72 , pp. 217-222
    • Mekinian, A.1    Lachassinne, E.2    Nicaise-Roland, P.3
  • 123
    • 67650672350 scopus 로고    scopus 로고
    • Follow-up of children exposed antenatally to immunosuppressive drugs
    • Motta M, Tincani A, Meroni PL, Cimaz R. Follow-up of children exposed antenatally to immunosuppressive drugs. Rheumatology (Oxford). 2008 ; 47(Suppl. 3): iii32 - iii34
    • (2008) Rheumatology (Oxford) , vol.473
    • Motta, M.1    Tincani, A.2    Meroni, P.L.3    Cimaz, R.4
  • 124
    • 33847390679 scopus 로고    scopus 로고
    • Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disorders
    • Cimaz R, Meregalli E, Biggioggero M, et al. Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disorders. Lupus. 2007 ; 16: 129-132
    • (2007) Lupus , vol.16 , pp. 129-132
    • Cimaz, R.1    Meregalli, E.2    Biggioggero, M.3
  • 125
    • 1842716671 scopus 로고    scopus 로고
    • Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy
    • Cimaz R, Meregalli E, Biggioggero M, et al. Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. Toxicol Lett. 2004 ; 149: 155-162
    • (2004) Toxicol Lett , vol.149 , pp. 155-162
    • Cimaz, R.1    Meregalli, E.2    Biggioggero, M.3
  • 126
    • 35148872630 scopus 로고    scopus 로고
    • Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents
    • Motta M, Ciardelli L, Marconi M, et al. Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents. Am J Perinatol. 2007 ; 24: 441-447
    • (2007) Am J Perinatol , vol.24 , pp. 441-447
    • Motta, M.1    Ciardelli, L.2    Marconi, M.3
  • 127
    • 84876716041 scopus 로고    scopus 로고
    • In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus
    • Marder W, Ganser MA, Romero V, et al. In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2013 ; 65: 759-766
    • (2013) Arthritis Care Res (Hoboken) , vol.65 , pp. 759-766
    • Marder, W.1    Ganser, M.A.2    Romero, V.3
  • 128
    • 33745243801 scopus 로고    scopus 로고
    • Anti-inflammatory and immunosuppressive drugs and reproduction
    • Ostensen M, Khamashta MA, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006 ; 8: 209-227
    • (2006) Arthritis Res Ther , vol.8 , pp. 209-227
    • Ostensen, M.1    Khamashta, M.A.2    Lockshin, M.3
  • 129
    • 84879232359 scopus 로고    scopus 로고
    • Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: A prospective cohort study
    • Nezvalova-Henriksen K, Spigset O, Nordeng H. Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: A prospective cohort study. BJOG. 2013 ; 120: 948-959
    • (2013) BJOG , vol.120 , pp. 948-959
    • Nezvalova-Henriksen, K.1    Spigset, O.2    Nordeng, H.3
  • 130
    • 67449135232 scopus 로고    scopus 로고
    • Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases
    • Sperber K, Hom C, Chao CP, Shapiro D, Ash J. Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr Rheumatol Online J. 2009 ; 7: 9-9
    • (2009) Pediatr Rheumatol Online J , vol.7 , pp. 9-9
    • Sperber, K.1    Hom, C.2    Chao, C.P.3    Shapiro, D.4    Ash, J.5
  • 131
    • 84864760273 scopus 로고    scopus 로고
    • Long-term use of antimalarial drugs in rheumatic diseases
    • Jover JA, Leon L, Pato E, et al. Long-term use of antimalarial drugs in rheumatic diseases. Clin Exp Rheumatol. 2012 ; 30: 380-387
    • (2012) Clin Exp Rheumatol , vol.30 , pp. 380-387
    • Jover, J.A.1    Leon, L.2    Pato, E.3
  • 132
    • 0009451225 scopus 로고
    • The ototoxicity of chloroquine phosphate
    • Hart CW, Naunton RF. The ototoxicity of chloroquine phosphate. Arch Otolaryngol. 1964 ; 80: 407-412
    • (1964) Arch Otolaryngol , vol.80 , pp. 407-412
    • Hart, C.W.1    Naunton, R.F.2
  • 133
    • 0030940457 scopus 로고    scopus 로고
    • Placental 11b-hydroxysteroid dehydrogenase: A key regulatorof fetal glucocorticoid exposure
    • Benediktsson R, Calder AA, Edwards CRW, Seckl JR. Placental 11b-hydroxysteroid dehydrogenase: A key regulatorof fetal glucocorticoid exposure. Clin Endocrinol. 1997 ; 46: 161-166
    • (1997) Clin Endocrinol , vol.46 , pp. 161-166
    • Benediktsson, R.1    Calder, A.A.2    Edwards, C.R.W.3    Seckl, J.R.4
  • 136
    • 84875214914 scopus 로고    scopus 로고
    • Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease
    • Casanova MJ, Chaparro M, Domenech E, et al. Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol. 2013 ; 108: 433-440
    • (2013) Am J Gastroenterol , vol.108 , pp. 433-440
    • Casanova, M.J.1    Chaparro, M.2    Domenech, E.3
  • 137
  • 138
    • 84870061265 scopus 로고    scopus 로고
    • Pharmacokinetics of tacrolimus during pregnancy
    • Zheng S, Easterling TR, Umans JG, et al. Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit. 2012 ; 34: 660-670
    • (2012) Ther Drug Monit , vol.34 , pp. 660-670
    • Zheng, S.1    Easterling, T.R.2    Umans, J.G.3
  • 140
    • 84876286990 scopus 로고    scopus 로고
    • Interpreting tacrolimus concentrations during pregnancy and postpartum
    • Hebert MF, Zheng S, Hays K, et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation. 2013 ; 95: 908-915
    • (2013) Transplantation , vol.95 , pp. 908-915
    • Hebert, M.F.1    Zheng, S.2    Hays, K.3
  • 142
    • 84878152297 scopus 로고    scopus 로고
    • Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine
    • Fischer-Betz R, Specker C, Brinks R, Aringer M, Schneider M. Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine. Rheumatology (Oxford). 2013 ; 52: 1070-1076
    • (2013) Rheumatology (Oxford) , vol.52 , pp. 1070-1076
    • Fischer-Betz, R.1    Specker, C.2    Brinks, R.3    Aringer, M.4    Schneider, M.5
  • 143
    • 44849130427 scopus 로고    scopus 로고
    • Lupus and pregnancy: Ten questions and some answers
    • Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: Ten questions and some answers. Lupus. 2008 ; 17: 416-420
    • (2008) Lupus , vol.17 , pp. 416-420
    • Ruiz-Irastorza, G.1    Khamashta, M.A.2
  • 144
    • 84885602479 scopus 로고    scopus 로고
    • Benlysta Ò (Belimumab). Package insert. USA: Human Genome Sciences and GlaxoSmithKline, March 2011
    • Benlysta Ò (Belimumab). Package insert. USA: Human Genome Sciences and GlaxoSmithKline, March 2011.
  • 145
    • 66249114343 scopus 로고    scopus 로고
    • Biologic therapy and pregnancy outcomes in women with rheumatic diseases
    • Vinet E, Pineau C, Gordon C, Clarke A, Bernatsky SR. Biologic therapy and pregnancy outcomes in women with rheumatic diseases. Arthritis Rheum. 2009 ; 61: 587-592
    • (2009) Arthritis Rheum , vol.61 , pp. 587-592
    • Vinet, E.1    Pineau, C.2    Gordon, C.3    Clarke, A.4    Bernatsky, S.R.5
  • 146
    • 79551617381 scopus 로고    scopus 로고
    • Pregnancy outcomes after maternal exposure to rituximab
    • Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011 ; 117: 1499-1506
    • (2011) Blood , vol.117 , pp. 1499-1506
    • Chakravarty, E.F.1    Murray, E.R.2    Kelman, A.3    Farmer, P.4
  • 147
    • 79952652279 scopus 로고    scopus 로고
    • Sildenafil citrate therapy for severe early-onset intrauterine growth restriction
    • von Dadelszen P, Dwinnell S, Magee LA, et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG. 2011 ; 118: 624-628
    • (2011) BJOG , vol.118 , pp. 624-628
    • Von Dadelszen, P.1    Dwinnell, S.2    Magee, L.A.3
  • 148
    • 27444435082 scopus 로고    scopus 로고
    • Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy
    • Bendayan D, Hod M, Oron G, et al. Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol. 2005 ; 106: 1206-1210
    • (2005) Obstet Gynecol , vol.106 , pp. 1206-1210
    • Bendayan, D.1    Hod, M.2    Oron, G.3
  • 149
    • 84865104002 scopus 로고    scopus 로고
    • The fetal safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers
    • Moretti ME, Caprara D, Drehuta I, et al. The fetal safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers. Obstet Gynecol Int. 2012 ; 2012: 658310-658310
    • (2012) Obstet Gynecol Int , vol.2012 , pp. 658310-658310
    • Moretti, M.E.1    Caprara, D.2    Drehuta, I.3
  • 150
    • 33144461691 scopus 로고    scopus 로고
    • Teratogenicity with angiotensin II receptor antagonists in pregnancy
    • Boix E, Zapater P, Picó A, Moreno O. Teratogenicity with angiotensin II receptor antagonists in pregnancy. J Endocrinol Invest. 2005 ; 28: 1029-1031
    • (2005) J Endocrinol Invest , vol.28 , pp. 1029-1031
    • Boix, E.1    Zapater, P.2    Picó, A.3    Moreno, O.4
  • 151
    • 84860581244 scopus 로고    scopus 로고
    • Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: A retrospective cohort study
    • Li DK, Yang C, Andrade S, Tavares V, Ferber JR. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: A retrospective cohort study. BMJ. 2011 ; 343: d5931 - d5931
    • (2011) BMJ , vol.343
    • Li, D.K.1    Yang, C.2    Andrade, S.3    Tavares, V.4    Ferber, J.R.5
  • 152
    • 77955037423 scopus 로고    scopus 로고
    • RCOG Green-top Guidelines No. 37 accessed August 2013
    • RCOG. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-top Guidelines No. 37, 2009:1-35, http://www.rcog.org.uk/ womens-health/clinical-guidance/reducing-risk-of-thrombosis-greentop37 (accessed August 2013).
    • (2009) Reducing the Risk of Thrombosis and Embolism during Pregnancy and the Puerperium , pp. 1-35
  • 153
    • 2342455100 scopus 로고    scopus 로고
    • Minor transplacental passage of fondoparinux in vivo
    • Dempfle CEH. Minor transplacental passage of fondoparinux in vivo. N Engl J Med. 2004 ; 350: 1914-1915
    • (2004) N Engl J Med , vol.350 , pp. 1914-1915
    • Dempfle, C.E.H.1
  • 154
    • 84855517874 scopus 로고    scopus 로고
    • The use of bisphosphonates in women prior to or during pregnancy and lactation
    • Stathopoulos EP, Liakou CG, Katsalira A, et al. The use of bisphosphonates in women prior to or during pregnancy and lactation. Hormones (Athens). 2011 ; 10: 280-291
    • (2011) Hormones (Athens) , vol.10 , pp. 280-291
    • Stathopoulos, E.P.1    Liakou, C.G.2    Katsalira, A.3
  • 156
    • 84873728092 scopus 로고    scopus 로고
    • Pregnancy outcome following maternal exposure to statins: A multicentre prospective study
    • Winterfeld U, Allignol A, Panchaud A, et al. Pregnancy outcome following maternal exposure to statins: A multicentre prospective study. BJOG. 2013 ; 120: 463-471
    • (2013) BJOG , vol.120 , pp. 463-471
    • Winterfeld, U.1    Allignol, A.2    Panchaud, A.3
  • 157
    • 79952145885 scopus 로고    scopus 로고
    • Pravastatin induces placental growth factor (PGF) and ameliorates pre-eclampsia in a mouse model
    • Kumasawa K, Ikawa M, Kidoya H, et al. Pravastatin induces placental growth factor (PGF) and ameliorates pre-eclampsia in a mouse model. Proc Natl Acad Sci U S A. 2011 ; 108: 1451-1455
    • (2011) Proc Natl Acad Sci U S A , vol.108 , pp. 1451-1455
    • Kumasawa, K.1    Ikawa, M.2    Kidoya, H.3
  • 158
    • 78149463756 scopus 로고    scopus 로고
    • A new mouse model to explore therapies for pre-eclampsia
    • Ahmed A, Singh J, Khan Y, Seshan SV, Girardi G. A new mouse model to explore therapies for pre-eclampsia. PLoS One. 2011 ; 5: e13663 - e13663
    • (2011) PLoS One , vol.5
    • Ahmed, A.1    Singh, J.2    Khan, Y.3    Seshan, S.V.4    Girardi, G.5
  • 159
    • 84873828168 scopus 로고    scopus 로고
    • Pravastatin for the prevention of preeclampsia in high-risk pregnant women
    • Costantine MM, Cleary K. Pravastatin for the prevention of preeclampsia in high-risk pregnant women. Obstet Gynecol. 2013 ; 121: 349-353
    • (2013) Obstet Gynecol , vol.121 , pp. 349-353
    • Costantine, M.M.1    Cleary, K.2
  • 160
    • 33644865455 scopus 로고    scopus 로고
    • The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome
    • Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford). 2006 ; 45: 332-338
    • (2006) Rheumatology (Oxford) , vol.45 , pp. 332-338
    • Le Thi Huong, D.1    Wechsler, B.2    Vauthier-Brouzes, D.3
  • 161
    • 33749628533 scopus 로고    scopus 로고
    • Uterine artery Doppler in predicting pregnancy outcome in women with connective tissue disorders
    • Castellino G, Capucci R, Govoni M, Mollica G, Trotta F. Uterine artery Doppler in predicting pregnancy outcome in women with connective tissue disorders. Rheumatology (Oxford). 2006 ; 45: 1174-1175
    • (2006) Rheumatology (Oxford) , vol.45 , pp. 1174-1175
    • Castellino, G.1    Capucci, R.2    Govoni, M.3    Mollica, G.4    Trotta, F.5
  • 162
    • 41149176488 scopus 로고    scopus 로고
    • Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: A systematic review and bivariable meta-analysis
    • Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: A systematic review and bivariable meta-analysis. CMAJ. 2008 ; 178: 701-711
    • (2008) CMAJ , vol.178 , pp. 701-711
    • Cnossen, J.S.1    Morris, R.K.2    Ter Riet, G.3
  • 163
    • 79251542678 scopus 로고    scopus 로고
    • Fetal umbilical artery Doppler to predict compromise of fetal/neonatal wellbeing in a high-risk population: Systematic review and bivariate meta-analysis
    • Morris RK, Malin G, Robson SC, Kleijnen J, Zamora J, Khan KS. Fetal umbilical artery Doppler to predict compromise of fetal/neonatal wellbeing in a high-risk population: Systematic review and bivariate meta-analysis. Ultrasound Obstet Gynecol. 2011 ; 37: 135-142
    • (2011) Ultrasound Obstet Gynecol , vol.37 , pp. 135-142
    • Morris, R.K.1    Malin, G.2    Robson, S.C.3    Kleijnen, J.4    Zamora, J.5    Khan, K.S.6
  • 164
    • 84885670619 scopus 로고    scopus 로고
    • RCOG Scientific impact paper No. 23 accessed August 2013
    • RCOG. Diagnosis and treatment of gestational diabetes. Scientific impact paper No. 23, http://www.rcog.org.uk/files/rcog-corp/uploaded-files/SIP-No-23. pdf (2011, accessed August 2013).
    • (2011) Diagnosis and Treatment of Gestational Diabetes
  • 165
    • 34249034723 scopus 로고    scopus 로고
    • Antiplatelet agents for preventing pre-eclampsia and its complications
    • Duley L, Henderson-Smart DJ, Meher S, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007 ; 2: CD004659 - CD004659
    • (2007) Cochrane Database Syst Rev , vol.2
    • Duley, L.1    Henderson-Smart, D.J.2    Meher, S.3
  • 166
    • 34249001303 scopus 로고    scopus 로고
    • Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data
    • Askie LM, Duley L, Henderson-Smart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet. 2007 ; 369: 1791-1798
    • (2007) Lancet , vol.369 , pp. 1791-1798
    • Askie, L.M.1    Duley, L.2    Henderson-Smart, D.J.3
  • 167
    • 84864278628 scopus 로고    scopus 로고
    • Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: A systematic review and meta-analysis
    • Roberge S, Giguere Y, Villa P, et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: A systematic review and meta-analysis. Am J Perinatol. 2012 ; 29: 551-556
    • (2012) Am J Perinatol , vol.29 , pp. 551-556
    • Roberge, S.1    Giguere, Y.2    Villa, P.3
  • 168
    • 84876571215 scopus 로고    scopus 로고
    • Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: A meta-analysis
    • Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: A meta-analysis. Ultrasound Obstet Gynaecol. 2013 ; 41: 491-499
    • (2013) Ultrasound Obstet Gynaecol , vol.41 , pp. 491-499
    • Roberge, S.1    Nicolaides, K.H.2    Demers, S.3    Villa, P.4    Bujold, E.5
  • 169
    • 84874164702 scopus 로고    scopus 로고
    • Chronotherapy with low-dose aspirin for prevention of complications in pregnancy
    • Ayala DE, Ucieda R, Hermida RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int. 2013 ; 30: 260-279
    • (2013) Chronobiol Int , vol.30 , pp. 260-279
    • Ayala, D.E.1    Ucieda, R.2    Hermida, R.C.3
  • 171
    • 84921705962 scopus 로고    scopus 로고
    • Prevention of recurrent miscarriage for women with antiphospholipid antibody or Lupus anticoagulant
    • Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or Lupus anticoagulant. Cochrane Database Syst Rev. 2005 ; 18: CD002859 - CD002859
    • (2005) Cochrane Database Syst Rev , vol.18
    • Empson, M.1    Lassere, M.2    Craig, J.3    Scott, J.4
  • 172
    • 84882990161 scopus 로고    scopus 로고
    • Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes
    • Soh MC, Pasupathy D, Gray G, Nelson-Piercy C. Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes. Rheumatology (Oxford). 2013 ; 52: 1642-1647
    • (2013) Rheumatology (Oxford) , vol.52 , pp. 1642-1647
    • Soh, M.C.1    Pasupathy, D.2    Gray, G.3    Nelson-Piercy, C.4
  • 173
    • 79953309488 scopus 로고    scopus 로고
    • Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010
    • Branch DW. Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010. Lupus. 2011 ; 20: 158-164
    • (2011) Lupus , vol.20 , pp. 158-164
    • Branch, D.W.1
  • 174
    • 77955954066 scopus 로고    scopus 로고
    • Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
    • Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2010 ; 8: CD001059 - CD001059
    • (2010) Cochrane Database Syst Rev , vol.8
    • Hofmeyr, G.J.1    Lawrie, T.A.2    Atallah, A.N.3    Duley, L.4
  • 175
    • 84856809942 scopus 로고    scopus 로고
    • VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 ; 141: e691S - e736S
    • (2012) Chest , vol.141
    • Bates, S.M.1    Greer, I.A.2    Middeldorp, S.3
  • 177
    • 77952981639 scopus 로고    scopus 로고
    • Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: A systematic review and meta-analysis
    • Ziakas PD, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: A systematic review and meta-analysis. Obstet Gynecol. 2010 ; 115: 1256-1262
    • (2010) Obstet Gynecol , vol.115 , pp. 1256-1262
    • Ziakas, P.D.1    Pavlou, M.2    Voulgarelis, M.3
  • 178
    • 84880469883 scopus 로고    scopus 로고
    • Risk factors for first venous thromboembolism around pregnancy: A population-based cohort study from the United Kingdom
    • Sultan AA, Tata LJ, West J, et al. Risk factors for first venous thromboembolism around pregnancy: A population-based cohort study from the United Kingdom. Blood. 2013 ; 121: 3953-3961
    • (2013) Blood , vol.121 , pp. 3953-3961
    • Sultan, A.A.1    Tata, L.J.2    West, J.3
  • 179
    • 74549191939 scopus 로고    scopus 로고
    • Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition)
    • Horlocker T, Wedel D, Rowlingson J, Enneking F. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med. 2010 ; 35: 64-101
    • (2010) Reg Anesth Pain Med , vol.35 , pp. 64-101
    • Horlocker, T.1    Wedel, D.2    Rowlingson, J.3    Enneking, F.4
  • 180
    • 84856804836 scopus 로고    scopus 로고
    • Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 ; 141: e326S - e350S
    • (2012) Chest , vol.141
    • Douketis, J.D.1    Spyropoulos, A.C.2    Spencer, F.A.3
  • 181
    • 3442901073 scopus 로고    scopus 로고
    • Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: Prospective analysis of 404 individuals
    • Girón-González JA, García del Río E, Rodríguez C, Rodríguez-Martorell J, Serrano A. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: Prospective analysis of 404 individuals. J Rheumatol. 2004 ; 31: 1560-1567
    • (2004) J Rheumatol , vol.31 , pp. 1560-1567
    • Giron-Gonzalez, J.A.1    Garcia Del Rio, E.2    Rodriguez, C.3    Rodriguez-Martorell, J.4    Serrano, A.5
  • 182
    • 79955815184 scopus 로고    scopus 로고
    • Risk factors for a first thrombotic event in antiphospholipid antibody carriers: A prospective multicentre follow-up study
    • Ruffatti A, Del Ross T, Ciprian M, et al. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: A prospective multicentre follow-up study. Ann Rheum Dis. 2011 ; 70: 1083-1086
    • (2011) Ann Rheum Dis , vol.70 , pp. 1083-1086
    • Ruffatti, A.1    Del Ross, T.2    Ciprian, M.3
  • 183
    • 79953309488 scopus 로고    scopus 로고
    • Obstetric task force. Report of the Obestetric Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010
    • Branch W. Obstetric task force. Report of the Obestetric Task Force: 13th
    • (2010) Lupus , vol.20 , pp. 158-164
    • Branch, W.1
  • 184
    • 79958103071 scopus 로고    scopus 로고
    • Contraceptive counseling and use among women with systemic lupus erythematosus: A gap in health care quality?
    • Yazdany J, Trupin L, Kaiser R, et al. Contraceptive counseling and use among women with systemic lupus erythematosus: A gap in health care quality?. Arthritis Care Res. 2011 ; 63: 358-365
    • (2011) Arthritis Care Res , vol.63 , pp. 358-365
    • Yazdany, J.1    Trupin, L.2    Kaiser, R.3
  • 185
    • 79958154399 scopus 로고    scopus 로고
    • Connective tissue diseases: Contraception counselling in SLE - An often forgotten duty?
    • Ostensen M. Connective tissue diseases: Contraception counselling in SLE - an often forgotten duty?. Nat Rev Rheumatol. 2011 ; 7: 315-316
    • (2011) Nat Rev Rheumatol , vol.7 , pp. 315-316
    • Ostensen, M.1
  • 186
    • 68949084933 scopus 로고    scopus 로고
    • Safety of contraceptive method use among women with systemic lupus erythematosus. A systematic review
    • Culwell KR, Curtis KM, Del Carmen Cravioto M. Safety of contraceptive method use among women with systemic lupus erythematosus. A systematic review. Obstet Gynecol. 2009 ; 114: 341-353
    • (2009) Obstet Gynecol , vol.114 , pp. 341-353
    • Culwell, K.R.1    Curtis, K.M.2    Del Carmen Cravioto, M.3
  • 187
    • 0026056511 scopus 로고
    • Efficacy of the simultaneous use of condoms and spermicides
    • Kestelman P, Trussell J. Efficacy of the simultaneous use of condoms and spermicides. Fam Plann Perspect. 1991 ; 23: 226-227, 232
    • (1991) Fam Plann Perspect , vol.23 , pp. 226-227
    • Kestelman, P.1    Trussell, J.2
  • 189
    • 28944431771 scopus 로고    scopus 로고
    • A trial of contraceptive methods in women with systemic lupus erythematosus
    • Sánchez-Guerrero J, Uribe AG, Jiménez-Santana L, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med. 2005 ; 353: 2539-2549
    • (2005) N Engl J Med , vol.353 , pp. 2539-2549
    • Sanchez-Guerrero, J.1    Uribe, A.G.2    Jimenez-Santana, L.3
  • 190
    • 28944445445 scopus 로고    scopus 로고
    • Combined oral contraceptives in women with systemic lupus erythematosus
    • Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005 ; 353: 2550-2558
    • (2005) N Engl J Med , vol.353 , pp. 2550-2558
    • Petri, M.1    Kim, M.Y.2    Kalunian, K.C.3
  • 192
    • 84884890847 scopus 로고    scopus 로고
    • RCOG Green-top Guidelines No. 40 accessed August 2013
    • RCOG. Venous thromboembolism and hormonal contraception. Green-top Guidelines No. 40, 2010: 1-13, http://www.rcog.org.uk/files/rcog-corp/ GTG40VenousThromboEmbolism0910.pdf (accessed August 2013).
    • (2010) Venous Thromboembolism and Hormonal Contraception , pp. 1-13
  • 193
    • 79951512461 scopus 로고    scopus 로고
    • Pregnane progestin contraception in systemic lupus erythematosus: A longitudinal study of 187 patients
    • Chabbert-Buffet N, Amoura Z, Scarabin PY, et al. Pregnane progestin contraception in systemic lupus erythematosus: A longitudinal study of 187 patients. Contraception. 2011 ; 83: 229-237
    • (2011) Contraception , vol.83 , pp. 229-237
    • Chabbert-Buffet, N.1    Amoura, Z.2    Scarabin, P.Y.3
  • 194
    • 38349184212 scopus 로고    scopus 로고
    • Bone density recovery after depot medroxyprogesterone acetate injectable contraception use
    • Kaunitz AM, Arias R, McClung M. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use. Contraception. 2008 ; 77: 67-76
    • (2008) Contraception , vol.77 , pp. 67-76
    • Kaunitz, A.M.1    Arias, R.2    McClung, M.3
  • 195
    • 79951512625 scopus 로고    scopus 로고
    • The effect of depot medroxyprogesterone acetate DMPA on bone mineral density BMD and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age
    • Gai L, Zhang J, Zhang H, Gai P, Zhou L, Liu Y. The effect of depot medroxyprogesterone acetate DMPA on bone mineral density BMD and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age. Contraception. 2011 ; 83: 218-222
    • (2011) Contraception , vol.83 , pp. 218-222
    • Gai, L.1    Zhang, J.2    Zhang, H.3    Gai, P.4    Zhou, L.5    Liu, Y.6
  • 196
    • 77956635509 scopus 로고    scopus 로고
    • Managing contraception and pregnancy in the rheumatologic diseases
    • Clowse MEB. Managing contraception and pregnancy in the rheumatologic diseases. Best Pract Res Clin Rheumatol. 2010 ; 24: 373-385
    • (2010) Best Pract Res Clin Rheumatol , vol.24 , pp. 373-385
    • Clowse, M.E.B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.